Journal
NATURE REVIEWS CANCER
Volume 14, Issue 11, Pages 747-753Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3819
Keywords
-
Categories
Funding
- Cancer Research UK [A13086]
- Ovarian Cancer Action, London, UK
- Cancer Research UK [13086, 15954] Funding Source: researchfish
- Ovarian Cancer Action [OCA3] Funding Source: researchfish
Ask authors/readers for more resources
Epigenetic events, which are somatically inherited through cell division, are potential drivers of acquired drug resistance in cancer. The high rate of epigenetic change in tumours generates diversity in gene expression patterns that can rapidly evolve through drug selection during treatment, leading to the development of acquired resistance. This will potentially confound stratified chemotherapy decisions that are solely based on mutation biomarkers. Poised epigenetic states in tumour cells may drive multistep epigenetic fixation of gene expression during the acquisition of drug resistance, which has implications for clinical strategies to prevent the emergence of drug resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available